Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability

  • Authors:
    • Dongkai Guo
    • Yao Zhu
    • Hongfeng Wang
    • Guanghui Wang
    • Cheng Wang
    • Haigang Ren
  • View Affiliations / Copyright

    Affiliations: Laboratory of Clinical Pharmacy, Department of Pharmacy, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou, Jiangsu 215153, P.R. China, Laboratory of Molecular Neuropathology, Jiangsu Key Laboratory of Neuropsychiatric Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, P.R. China
    Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2639-2648
    |
    Published online on: July 10, 2020
       https://doi.org/10.3892/etm.2020.8988
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Circadian rhythm serves an essential role in numerous physiological functions. Circadian oscillations are organized by circadian clock components at the molecular level. The precision of the circadian clock is controlled by transcriptional‑translational negative feedback loops, as well as post‑translational modifications of clock proteins, including ubiquitination; however, the influence of E3 ligases on clock protein ubiquitination requires further investigation. The results of co‑immunoprecipitation and immunofluorescent localization, indicated that the endoplasmic reticulum transmembrane E3 ubiquitin ligase HRD1, encoded by the synoviolin 1 gene, interacted with brain and muscle ARNT‑like 1 (BMAL1) and enhanced BMAL1 protein ubiquitination. In addition, the results of western blotting and reverse transcription‑​quantitative PCR suggested that HRD1 promoted K48‑associated polyubiquitination of BMAL1 and thus mediated its degradation via the ubiquitin‑proteasome system. Furthermore, gene knockdown and gene overexpression assays revealed that HRD1‑dependent degradation of BMAL1 protein regulated the expression of BMAL1 target genes and the amplitude of circadian oscillations in mammalian cells. The findings of the current study indicate that HRD1 may influence the regulation of circadian rhythm via modulation of BMAL1 stability.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Cao Y and Wang RH: Associations among metabolism, circadian rhythm and age-associated diseases. Aging Dis. 8:314–333. 2017.PubMed/NCBI View Article : Google Scholar

2 

Mitsumoto Y and Mori A: Acute restraint stress augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity via increased toxin uptake into the brain in C57BL/6 mice. Neurosci Bull. 34:849–853. 2018.PubMed/NCBI View Article : Google Scholar

3 

Li X and Li X: The antidepressant effect of light therapy from retinal projections. Neurosci Bull. 34:359–368. 2018.PubMed/NCBI View Article : Google Scholar

4 

Poggiogalle E, Jamshed H and Peterson CM: Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism. 84:11–27. 2018.PubMed/NCBI View Article : Google Scholar

5 

Brown SA: Circadian metabolism: From mechanisms to metabolomics and medicine. Trends Endocrinol Metab. 27:415–426. 2016.PubMed/NCBI View Article : Google Scholar

6 

Mendoza-Viveros L, Bouchard-Cannon P, Hegazi S, Cheng AH, Pastore S and Cheng HM: Molecular modulators of the circadian clock: Lessons from flies and mice. Cell Mol Life Sci. 74:1035–1059. 2017.PubMed/NCBI View Article : Google Scholar

7 

Papazyan R, Zhang Y and Lazar MA: Genetic and epigenomic mechanisms of mammalian circadian transcription. Nat Struct Mol Biol. 23:1045–1052. 2016.PubMed/NCBI View Article : Google Scholar

8 

Chen D, Li YP, Yu YX, Zhou T, Liu C, Fei EK, Gao F, Mu CC, Ren HG and Wang GH: Dendritic cell nuclear protein-1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N-acetyltransferase in C6 cells. Acta Pharmacol Sin. 39:597–606. 2018.PubMed/NCBI View Article : Google Scholar

9 

Lim C and Allada R: Emerging roles for post-transcriptional regulation in circadian clocks. Nat Neurosci. 16:1544–1550. 2013.PubMed/NCBI View Article : Google Scholar

10 

Preußner M and Heyd F: Post-transcriptional control of the mammalian circadian clock: Implications for health and disease. Pflugers Arch. 468:983–991. 2016.PubMed/NCBI View Article : Google Scholar

11 

Beckwith EJ and Yanovsky MJ: Circadian regulation of gene expression: At the crossroads of transcriptional and post-transcriptional regulatory networks. Curr Opin Genet Dev. 27:35–42. 2014.PubMed/NCBI View Article : Google Scholar

12 

Swatek KN and Komander D: Ubiquitin modifications. Cell Res. 26:399–422. 2016.PubMed/NCBI View Article : Google Scholar

13 

Covill-Cooke C, Howden JH, Birsa N and Kittler JT: Ubiquitination at the mitochondria in neuronal health and disease. Neurochem Int. 117:55–64. 2018.PubMed/NCBI View Article : Google Scholar

14 

Rape M: Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 19:59–70. 2018.PubMed/NCBI View Article : Google Scholar

15 

Lecker SH, Goldberg AL and Mitch WE: Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 17:1807–1819. 2006.PubMed/NCBI View Article : Google Scholar

16 

Myung J, Kim KB and Crews CM: The ubiquitin-proteasome pathway and proteasome inhibitors. Med Res Rev. 21:245–273. 2001.PubMed/NCBI View Article : Google Scholar

17 

Stojkovic K, Wing SS and Cermakian N: A central role for ubiquitination within a circadian clock protein modification code. Front Mol Neurosci. 7(69)2014.PubMed/NCBI View Article : Google Scholar

18 

Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI, Draetta GF and Pagano M: SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins. Science. 316:900–904. 2007.PubMed/NCBI View Article : Google Scholar

19 

Xing W, Busino L, Hinds TR, Marionni ST, Saifee NH, Bush MF, Pagano M and Zheng N: SCF(FBXL3) ubiquitin ligase targets cryptochromes at their cofactor pocket. Nature. 496:64–68. 2013.PubMed/NCBI View Article : Google Scholar

20 

Yoo SH, Mohawk JA, Siepka SM, Shan Y, Huh SK, Hong HK, Kornblum I, Kumar V, Koike N, Xu M, et al: Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm. Cell. 152:1091–1105. 2013.PubMed/NCBI View Article : Google Scholar

21 

Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, et al: Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Nature. 485:123–127. 2012.PubMed/NCBI View Article : Google Scholar

22 

Zhang Y, Fang B, Emmett MJ, Damle M, Sun Z, Feng D, Armour SM, Remsberg JR, Jager J, Soccio RE, et al: GENE REGULATION Discrete functions of nuclear receptor Rev-erbα couple metabolism to the clock. Science. 348:1488–1492. 2015.PubMed/NCBI View Article : Google Scholar

23 

Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U and Schibler U: The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110:251–260. 2002.PubMed/NCBI View Article : Google Scholar

24 

Yin L, Joshi S, Wu N, Tong X and Lazar MA: E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha. Proc Natl Acad Sci USA. 107:11614–11619. 2010.PubMed/NCBI View Article : Google Scholar

25 

Gossan NC, Zhang F, Guo B, Jin D, Yoshitane H, Yao A, Glossop N, Zhang YQ, Fukada Y and Meng QJ: The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res. 42:5765–5775. 2014.PubMed/NCBI View Article : Google Scholar

26 

Bordallo J, Plemper RK, Finger A and Wolf DH: Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. Mol Biol Cell. 9:209–222. 1998.PubMed/NCBI View Article : Google Scholar

27 

Kaneko M, Ishiguro M, Niinuma Y, Uesugi M and Nomura Y: Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 532:147–152. 2002.PubMed/NCBI View Article : Google Scholar

28 

Kikkert M, Doolman R, Dai M, Avner R, Hassink G, van Voorden S, Thanedar S, Roitelman J, Chau V and Wiertz E: Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem. 279:3525–3534. 2004.PubMed/NCBI View Article : Google Scholar

29 

Nomura J, Hosoi T, Kaneko M, Ozawa K, Nishi A and Nomura Y: Neuroprotection by endoplasmic reticulum stress-induced HRD1 and chaperones: Possible therapeutic targets for Alzheimer's and Parkinson's disease. Med Sci (Basel). 4(14)2016.PubMed/NCBI View Article : Google Scholar

30 

Mao J, Xia Q, Liu C, Ying Z, Wang H and Wang G: A critical role of Hrd1 in the regulation of optineurin degradation and aggresome formation. Hum Mol Genet. 26:1877–1889. 2017.PubMed/NCBI View Article : Google Scholar

31 

Guo DK, Zhu Y, Sun HY, Xu XY, Zhang S, Hao ZB, Wang GH, Mu CC and Ren HG: Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway. Acta Pharmacologica Sinica. 40:26–34. 2019.PubMed/NCBI View Article : Google Scholar

32 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

33 

Repouskou A, Sourlingas TG, Sekeri-Pataryas KE and Prombona A: The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. Chronobiol Int. 27:722–741. 2010.PubMed/NCBI View Article : Google Scholar

34 

Chang HC and Guarente L: SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell. 153:1448–1460. 2013.PubMed/NCBI View Article : Google Scholar

35 

Chilov D, Hofer T, Bauer C, Wenger RH and Gassmann M: Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J. 15:2613–2622. 2001.PubMed/NCBI View Article : Google Scholar

36 

Buhr ED and Takahashi JS: Molecular components of the mammalian circadian clock. Handb Exp Pharmacol. 3–27. 2013.PubMed/NCBI View Article : Google Scholar

37 

Musiek ES and Holtzman DM: Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science. 354:1004–1008. 2016.PubMed/NCBI View Article : Google Scholar

38 

Chen S, Yang J, Zhang Y, Duan C, Liu Q, Huang Z, Xu Y, Zhou L and Xu G: Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1. J Biol Chem. 293:11296–11309. 2018.PubMed/NCBI View Article : Google Scholar

39 

Chen S, Yang J, Yang L, Zhang Y, Zhou L, Liu Q, Duan C, Mieres CA, Zhou G and Xu G: Ubiquitin ligase TRAF2 attenuates the transcriptional activity of the core clock protein BMAL1 and affects the maximal Per1 mRNA level of the circadian clock in cells. FEBS J. 285:2987–3001. 2018.PubMed/NCBI View Article : Google Scholar

40 

Zhang Y, Duan C, Yang J, Chen S, Liu Q, Zhou L, Huang Z, Xu Y and Xu G: Deubiquitinating enzyme USP9X regulates cellular clock function by modulating the ubiquitination and degradation of a core circadian protein BMAL1. Biochem J. 475:1507–1522. 2018.PubMed/NCBI View Article : Google Scholar

41 

Lee Y, Lee J, Kwon I, Nakajima Y, Ohmiya Y, Son GH, Lee KH and Kim K: Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. J Cell Sci. 123:3547–3557. 2010.PubMed/NCBI View Article : Google Scholar

42 

Kondratov RV, Chernov MV, Kondratova AA, Gorbacheva VY, Gudkov AV and Antoch MP: BMAL1-dependent circadian oscillation of nuclear CLOCK: Posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system. Genes Dev. 17:1921–1932. 2003.PubMed/NCBI View Article : Google Scholar

43 

Kwon I, Lee J, Chang SH, Jung NC, Lee BJ, Son GH, Kim K and Lee KH: BMAL1 shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer. Mol Cell Biol. 26:7318–7330. 2006.PubMed/NCBI View Article : Google Scholar

44 

Miki T, Zhao Z and Lee CC: Interactive organization of the circadian core regulators PER2, BMAL1, CLOCK and PML. Sci Rep. 6(29174)2016.PubMed/NCBI View Article : Google Scholar

45 

Lipton JO, Yuan ED, Boyle LM, Ebrahimi-Fakhari D, Kwiatkowski E, Nathan A, Güttler T, Davis F, Asara JM and Sahin M: The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation. Cell. 161:1138–1151. 2015.PubMed/NCBI View Article : Google Scholar

46 

Behrends C and Harper JW: Constructing and decoding unconventional ubiquitin chains. Nat Struct Mol Biol. 18:520–528. 2011.PubMed/NCBI View Article : Google Scholar

47 

Hochstrasser M: Lingering mysteries of ubiquitin-chain assembly. Cell. 124:27–34. 2006.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guo D, Zhu Y, Wang H, Wang G, Wang C and Ren H: E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability. Exp Ther Med 20: 2639-2648, 2020.
APA
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., & Ren, H. (2020). E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability. Experimental and Therapeutic Medicine, 20, 2639-2648. https://doi.org/10.3892/etm.2020.8988
MLA
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., Ren, H."E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability". Experimental and Therapeutic Medicine 20.3 (2020): 2639-2648.
Chicago
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., Ren, H."E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2639-2648. https://doi.org/10.3892/etm.2020.8988
Copy and paste a formatted citation
x
Spandidos Publications style
Guo D, Zhu Y, Wang H, Wang G, Wang C and Ren H: E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability. Exp Ther Med 20: 2639-2648, 2020.
APA
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., & Ren, H. (2020). E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability. Experimental and Therapeutic Medicine, 20, 2639-2648. https://doi.org/10.3892/etm.2020.8988
MLA
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., Ren, H."E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability". Experimental and Therapeutic Medicine 20.3 (2020): 2639-2648.
Chicago
Guo, D., Zhu, Y., Wang, H., Wang, G., Wang, C., Ren, H."E3 ubiquitin ligase HRD1 modulates the circadian clock through regulation of BMAL1 stability". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2639-2648. https://doi.org/10.3892/etm.2020.8988
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team